IBNH Share Price | Ibn Al Haytham Hospital Co. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 2.02%

Poor long term growth as Net Sales has grown by an annual rate of 0.51% and Operating profit at -20.95% over the last 5 years
The company is Net-Debt Free

The company has declared negative results in Mar'2026 after 3 consecutive positive quarters

With ROE of 1.41%, it has a expensive valuation with a 0.00 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

JOD Million (Small Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.79

Return on Equity

1.41%

Price to Book

0.00

Revenue and Profits:

Net Sales:

3 Million

(Quarterly Results - Mar 2026)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

13.16%

6 Months

7.5%

1 Year

26.47%

2 Years

4.88%

3 Years

-14.0%

4 Years

-5.49%

5 Years

-19.63%

Ibn Al Haytham Hospital Co. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.51%

EBIT Growth (5y)

-20.95%

EBIT to Interest (avg)

-0.38

Debt to EBITDA (avg)

5.37

Net Debt to Equity (avg)

0.65

Sales to Capital Employed (avg)

0.50

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.02%

ROE (avg)

1.68%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

10.76

EV to EBITDA

6.06

EV to Capital Employed

0.44

EV to Sales

0.90

PEG Ratio

Dividend Yield

ROCE (Latest)

2.76%

ROE (Latest)

1.41%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.00% vs -10.34% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.60",
          "val2": "2.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.70%",
          "val2": "8.40%",
          "chgp": "-2.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.54% vs 4.42% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 200.00% vs 104.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.10",
          "val2": "11.80",
          "chgp": "2.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.80",
          "val2": "1.60",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.30%",
          "val2": "41.60%",
          "chgp": "1.97%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

2.60

Operating Profit (PBDIT) excl Other Income

0.20

Interest

0.30

0.20

50.00%

Exceptional Items

0.00

Consolidate Net Profit

-0.20

-0.10

-100.00%

Operating Profit Margin (Excl OI)

-15.70%

8.40%

-2.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.00% vs -10.34% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

12.10

11.80

2.54%

Operating Profit (PBDIT) excl Other Income

1.80

1.60

12.50%

Interest

0.80

Exceptional Items

-0.00

0.00

Consolidate Net Profit

0.30

0.10

200.00%

Operating Profit Margin (Excl OI)

61.30%

41.60%

1.97%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 2.54% vs 4.42% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 200.00% vs 104.00% in Dec 2024

All Annual Results

Company CV

About Ibn Al Haytham Hospital Co.

Ibn Al Haytham Hospital Co.

Hospital

Ibn Al Haytham Hospital Company PSC is a Jordan-based company engaged in the provision of medical services. The Company focuses on the investment in medical and commercial agency sectors, purchase and sale of medical equipments, entering into bids and tenders for the Company’s purpose, and investment in newly established companies. The Company operates a hospital that has a capacity of 200 beds and 38 clinics covering all medical specialties, which includes heart and arteries, endoscopy, ophthalmology, gynecology, and prematurity, as well as operating genetics laboratories, emergency section, pharmacy, intensive care unit, and laser hair removal center, among others.

Company Coordinates

Company Details

Tlaa' Ali,, PO Box 94614 AMMAN None : 11194

Tel: 962 6 5205555

Registrar Details